CAD 1.31
(-2.24%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -281.19 Million USD | 21.23% |
2022 | -481.81 Million USD | -86.61% |
2021 | -258.19 Million USD | -236.76% |
2020 | -76.67 Million USD | 14.07% |
2019 | -89.22 Million CAD | -21.91% |
2018 | -73.18 Million CAD | -1900.92% |
2017 | -3.65 Million CAD | -2202.7% |
2016 | -158.84 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -48.88 Million USD | -1.64% |
2024 Q1 | -65.15 Million USD | 25.98% |
2023 Q3 | -123.86 Million USD | -29.45% |
2023 FY | -379.52 Million USD | 21.23% |
2023 Q2 | -95.68 Million USD | -30.09% |
2023 Q1 | -73.55 Million USD | 79.19% |
2023 Q4 | -86.11 Million USD | 30.47% |
2022 Q3 | -69.69 Million CAD | -118.51% |
2022 FY | -481.81 Million USD | -86.61% |
2022 Q4 | -353.42 Million CAD | -407.11% |
2022 Q2 | -31.89 Million CAD | -26.0% |
2022 Q1 | -25.31 Million CAD | 27.09% |
2021 FY | -258.19 Million USD | -236.76% |
2021 Q4 | -34.72 Million CAD | 51.59% |
2021 Q3 | -71.71 Million CAD | 0.0% |
2020 FY | -76.67 Million USD | 14.07% |
2019 FY | -89.22 Million CAD | -21.91% |
2018 FY | -73.18 Million CAD | -1900.92% |
2017 FY | -3.65 Million CAD | -2202.7% |
2016 FY | -158.84 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aurora Cannabis Inc. | -69.32 Million CAD | -305.615% |
Avicanna Inc. | -8.74 Million CAD | -3116.252% |
Avant Brands Inc. | -5.07 Million CAD | -5446.292% |
Cardiol Therapeutics Inc. | -28.12 Million CAD | -899.695% |
Crescita Therapeutics Inc. | -1.98 Million CAD | -14058.963% |
Knight Therapeutics Inc. | -16.83 Million CAD | -1570.312% |
MediPharm Labs Corp. | -13.08 Million CAD | -2049.331% |
OrganiGram Holdings Inc. | -229.47 Million CAD | -22.538% |
Canopy Growth Corporation | -657.26 Million CAD | 57.217% |
Willow Biosciences Inc. | -13.02 Million CAD | -2058.239% |
Auxly Cannabis Group Inc. | -44.51 Million CAD | -531.747% |